Joseph Klausner

Medicine & Life Sciences

1. Neoplasms 100%
2. Extremities 91%
3. Thromboxanes 87%
4. Neoplasm Metastasis 87%
5. Sarcoma 83%
6. Ischemia 74%
7. Neutrophils 73%
8. Melanoma 71%
9. Perfusion 64%
10. Lung 62%
11. Lymph 60%
12. Restorative Proctocolectomy 60%
13. Melphalan 60%
14. Leukotriene B4 58%
15. Survival 58%
16. Tumor Necrosis Factor-alpha 57%
17. Transendothelial and Transepithelial Migration 55%
18. Reperfusion 55%
19. Liver 53%
20. Pancreatic Neoplasms 52%
21. Rectal Neoplasms 51%
22. Lung Injury 48%
23. Israel 44%
24. Capillary Permeability 43%
25. Lymph Nodes 42%
26. Wounds and Injuries 42%
27. Permeability 41%
28. Therapeutics 41%
29. Drug Therapy 39%
30. Neoadjuvant Therapy 39%
31. Adenocarcinoma 38%
32. Recurrence 35%
33. Pancreatitis 33%
34. Aggressive Fibromatosis 33%
35. Leukotrienes 31%
36. Colorectal Surgery 31%
37. Laparotomy 30%
38. Postoperative Complications 30%
39. Ulcerative Colitis 29%
40. Breast 29%
41. Pressure 29%
42. Pancreatic Intraductal Neoplasms 28%
43. Neuroendocrine Tumors 28%
44. Hemorrhage 28%
45. Kidney 27%
46. Adenomatous Polyposis Coli 27%
47. Free Radicals 27%
48. Leukocytes 26%
49. Pulmonary Edema 26%
50. Length of Stay 26%